Anebulo Pharmaceuticals (ANEB) Institutional Ownership $1.26 -0.16 (-10.95%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.28 +0.02 (+1.59%) As of 02/21/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)CurrentInstitutional OwnershipPercentage28.40%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$21.31MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$14.32K Get ANEB Insider Trade Alerts Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANEB Institutional Buying and Selling by Quarter Anebulo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 22NW LP15,467,300$25.99M18.5%+188.2%59.650% 2/14/2025 Nantahala Capital Management LLC3,036,325$5.10M0.2%+494.1%11.710% 2/7/2025 King Luther Capital Management Corp59,662$100K0.0%N/A0.230% 1/16/2025 LVW Advisors LLC632,516$1.06M0.1%-1.3%2.439% 1/16/2024 LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509% 2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116% 11/10/2022 Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994% 10/14/2022 LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888% 7/22/2022 LVW Advisors LLC700,000$3.64M0.7%N/A2.999% 8/18/2021 Ikarian Capital LLC174,811$1.20M0.1%N/A0.749% 8/17/2021 22NW LP3,343,565$22.80M6.1%N/A14.322% 8/17/2021 Boothbay Fund Management LLC19,835$135K0.0%N/A0.085% 8/13/2021 Laurion Capital Management LP225,000$1.55M0.0%N/A0.964% (Data available from 1/1/2016 forward) ANEB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANEB shares? During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: 22NW LP ($25.99M), Nantahala Capital Management LLC ($5.10M), and LVW Advisors LLC ($1.06M), King Luther Capital Management Corp ($100K).Learn more on ANEB's institutional investors. What percentage of Anebulo Pharmaceuticals stock is owned by institutional investors? 28.40% of Anebulo Pharmaceuticals stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings. Which institutional investors have been buying Anebulo Pharmaceuticals stock? The following institutional investors have purchased Anebulo Pharmaceuticals stock in the last 24 months: 22NW LP ($10.10M), Nantahala Capital Management LLC ($2.53M), and King Luther Capital Management Corp ($59.66K). How much institutional buying is happening at Anebulo Pharmaceuticals? Institutional investors have bought a total of 12,685,924 shares in the last 24 months. This purchase volume represents approximately $21.31M in transactions. Which Anebulo Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($37.82K). How much institutional selling is happening at Anebulo Pharmaceuticals? Institutional investors have sold a total of 37,815 shares in the last 24 months. This volume of shares sold represents approximately $85.21K in transactions. Related Companies BioXcel Therapeutics Major Shareholders Nkarta Major Shareholders Silence Therapeutics Major Shareholders Zentalis Pharmaceuticals Major Shareholders Fate Therapeutics Major Shareholders ADC Therapeutics Major Shareholders Sagimet Biosciences Major Shareholders Solid Biosciences Major Shareholders Puma Biotechnology Major Shareholders Biomea Fusion Major Shareholders This page (NASDAQ:ANEB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
